Hepatitis Viruses: Hepatitis B and Hepatitis D

A. Evans,C. Cohen,T. Block

Published 2014 in Unknown venue

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2014
Venue
Unknown venue
Publication date
Unknown publication date
Fields of study
Medicine
Identifiers
DOI 10.1007/978-1-4899-7448-8_32
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
2013cited by this paper
Breastfeeding Is Not a Risk Factor for Mother-to-Child Transmission of Hepatitis B Virus
2013cited by this paper
Chronic HBV Infection outside Treatment Guidelines: Is Treatment Needed?
2013cited by this paper
Chronic hepatitis B: what should be the goal for new therapies?
2013cited by this paper
Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis.
2013cited by this paper
Prevalence of chronic hepatitis B among foreign‐born persons living in the United States by country of origin
2012cited by this paper
The National Perinatal Hepatitis B Prevention Program, 1994–2008
2012cited by this paper
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
2012cited by this paper
Chronic hepatitis B infection.
2012cited by this paper
Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students.
2012cited by this paper
Noninvasive methods to assess liver disease in patients with hepatitis B or C.
2012cited by this paper
Epidemiology of Hepatitis D
2012cited by this paper
Occult HBV infection
2012cited by this paper
Molecular epidemiology of a large community-based outbreak of hepatitis B in Bristol, U.K.
2012cited by this paper
Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis
2012cited by this paper
Horizontal transmission of hepatitis B virus--why discuss when we can vaccinate?
2012cited by this paper
A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
2012cited by this paper
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
2012cited by this paper
Mother‐to‐infant transmission of hepatitis B virus: A Chinese experience
2011cited by this paper
Hepatitis D revival
2011cited by this paper
Hepatitis D virus: an update
2011cited by this paper
Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
2011cited by this paper
Manual for the surveillance of vaccine-preventable diseases. Chapter 18: Surveillance indicators
2011cited by this paper
Evaluation of current treatment recommendations for chronic hepatitis B: A 2011 update
2011cited by this paper
Is chronic hepatitis B being undertreated in the United States?
2011cited by this paper
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review
2011cited by this paper
The Management of Chronic Hepatitis B in Asian Americans
2011cited by this paper
Hepatitis delta virus.
2011cited by this paper
The clinical implications of hepatitis B virus genotype: Recent advances
2011cited by this paper
Molecular methods in the diagnosis and management of chronic hepatitis B
2010cited by this paper
Do we need to determine viral genotype in treating chronic hepatitis B?
2010cited by this paper
Bloodborne pathogen risk reduction activities in the body piercing and tattooing industry.
2010cited by this paper
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead
2010cited by this paper
Hepatitis D: Scenario in the Asia-Pacific region.
2010cited by this paper
Toward elimination and eradication of hepatitis B
2010cited by this paper
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.
2010cited by this paper
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
2010cited by this paper
Hepatitis B and D
2010cited by this paper
Factors involved in the development of fulminant hepatitis B: Are the mutations of hepatitis B virus implicated?
2009cited by this paper
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
2009cited by this paper
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
2009cited by this paper
Chronic hepatitis B: Update 2009
2009cited by this paper
The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B
2009cited by this paper
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
2009cited by this paper
The natural history of chronic hepatitis B virus infection
2009cited by this paper
Nonhospital Health CareAssociated Hepatitis B and C Virus Transmission: United States, 19982008
2009cited by this paper
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.
2009cited by this paper
The increasing prevalence of hepatitis delta virus (HDV) infection in South London
2008cited by this paper
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
2008cited by this paper
Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World
2008cited by this paper
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
2008cited by this paper
NIH consensus development statement on management of hepatitis B.
2008cited by this paper
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
2008cited by this paper
Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection.
2008cited by this paper
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment
2007cited by this paper
Hepatitis D virus infection—Not a vanishing disease in Europe!
2007cited by this paper
Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase
2007cited by this paper
Underestimation of chronic hepatitis B virus infection in the United States of America
2007cited by this paper
Hepatitis delta in Europe: Vanishing or refreshing?
2007cited by this paper
The enigma of concurrent hepatitis B surface antigen (HBsAg) and antibodies to HBsAg.
2007cited by this paper
Prevalence and Genetic Diversity of Hepatitis B and Delta Viruses in Pregnant Women in Gabon: Molecular Evidence that Hepatitis Delta Virus Clade 8 Originates from and Is Endemic in Central Africa
2007cited by this paper
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
2007cited by this paper
Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants.
2007cited by this paper
Erratum: Acute delta hepatitis in Italy: Incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign (Clinical Infectious Diseases (2007) 44 (e17-24))
2007cited by this paper
2. Hepatitis B
2007cited by this paper
Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
2007cited by this paper
Hepatitis B virus infection.
2007cited by this paper
Immunobiology and pathogenesis of viral hepatitis.
2006cited by this paper
Past HBV Viral Load as Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study
2006cited by this paper
Chronic hepatitis B: current epidemiology in the Americas and implications for management
2006cited by this paper
Hepatitis B virus infection: epidemiology and vaccination.
2006cited by this paper
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
2006cited by this paper
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006cited by this paper
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
2006cited by this paper
Eighth Major Clade for Hepatitis Delta Virus
2006cited by this paper
Molecular epidemiology of hepatitis B in England and Wales.
2005cited by this paper
Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu‐speaking sub‐saharan Africans
2005cited by this paper
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
2005cited by this paper
Yeast recombinant hepatitis B vaccine
2005cited by this paper
Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility.
2005cited by this paper
Epidemiology and Natural History of Hepatitis B
2005cited by this paper
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.
2005cited by this paper
Molecular virology of hepatitis B virus.
2004cited by this paper
Prevention of viral hepatitis in Italy.
2004cited by this paper
Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers
2004cited by this paper
The global burden of disease attributable to contaminated injections given in health care settings
2004cited by this paper
Hepatitis B virus infection--natural history and clinical consequences.
2004cited by this paper
Changing seroepidemiology of hepatitis B, C, and D virus infections in high‐risk populations
2004cited by this paper
Control of Communicable Diseases Manual
2004cited by this paper
Extrahepatic manifestations of chronic hepatitis B.
2004cited by this paper
Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth
2004cited by this paper
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.
2004cited by this paper
Action plan for liver disease research
2004cited by this paper
Delta hepatitis: an update.
2003cited by this paper
Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population
2003cited by this paper
Epidemiology of hepatitis B in Europe and worldwide.
2003cited by this paper
Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.
2003cited by this paper
Contamination by hepatitis B and C viruses in the dialysis setting.
2003cited by this paper
Clinical significance of hepatitis B virus genotypes
2002cited by this paper
Hepatitis B viral genotypes: Clinical relevance and molecular characteristics
2002cited by this paper

CITED BY

Hepatitis B Virus Awareness, Infection, and Screening Multiethnic Community Intervention for Foreign-Born Populations
2021cites this paper
Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income Countries
2021cites this paper
Exploring the Impact of Storytelling on Storytellers in a Hepatitis B Health Communication Context.
2020cites this paper
Prevalence of Hepatitis B Virus Infection among Pregnant Women in Jos, Nigeria
2020cites this paper